{"id":911186,"date":"2025-11-18T11:05:16","date_gmt":"2025-11-18T16:05:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/"},"modified":"2025-11-18T11:05:16","modified_gmt":"2025-11-18T16:05:16","slug":"alx-oncology-to-present-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/","title":{"rendered":"ALX Oncology to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., Nov.  18, 2025  (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc., (&#8220;ALX Oncology&#8221; or the &#8220;Company&#8221;) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37<sup>th<\/sup> Annual Global Healthcare Conference in New York.<\/p>\n<p>The details of the meetings are as follows:<\/p>\n<p>\n        <strong>Jefferies Global Healthcare Conference in London <\/strong>\n      <\/p>\n<p>Format: Fireside Chat <br \/>Date: Wednesday, November 19, 2025<br \/>Time: 11:30 AM GMT \/ 6:30 AM EST<br \/>Location: London, UK<br \/>Webcast link: Available\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A1XyJxO-7a1LMWfrde9LUP6-9P_mj2NBSfUl0p0e_fyxGIxRC_nOjGTHchUoX0eVntis78Vi8BzajO6YkhGwGy1vF_PjA8oUrBvwcTkPKMw=\" rel=\"nofollow\" target=\"_blank\">here<\/a><\/p>\n<p>\n        <strong>Piper Sandler 37<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Conference <\/strong>\n      <\/p>\n<p>Format: Fireside Chat<br \/>Date: Wednesday, December 3, 2025<br \/>Time: 9:30 AM EST<br \/>Location: New York, NY<br \/>Webcast link: Available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Kh1p0NeTYgdesfgtazeSp-k8TuxxImHiaBIYCvzWTv2oWW03Ni2jwJzsBCc-22PQ43kGGmgaY82gTYNSeE4rwDv4TfXGKA4xZoTsLg3rIrAdohcEYUsjnyUpZHqOstN4EVqbvXKpUQDkuKa6924IyQ==\" rel=\"nofollow\" target=\"_blank\"> here<\/a><\/p>\n<p>The webcasts of the Jefferies London and Piper Sandler fireside chats can be accessed by visiting the Investors section of ALX Oncology\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=58Ac7qaM5O07VB48oQI9TA3ekwDcZc0ZP5Ho6ESvzwPbpZe7BTjoizaPBne5jV27-x2_1DiEeTD5D61TtsTnHikgK3iq88wJuZ7K9Ykhub4=\" rel=\"nofollow\" target=\"_blank\">www.alxoncology.com<\/a> under the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_7_7z1ZG-asTqaH7k76_e5E5LzF5W7YhiYECkVnEN0Nid1D_2NK27DgP_gMvoCELWwr-WAxYKDxqomTdVvvsdxV5kXS6whbte2Qf4D8x_h1Edd_VST8e6ymhPknZGUSS\" rel=\"nofollow\" target=\"_blank\">Events<\/a> section of the Events and Presentations tab. Replays of the webcasts will be archived for up to 90 days following the fireside chat dates.<\/p>\n<p>\n        <strong>About ALX Oncology<\/strong><br \/>\n        <br \/>ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives. ALX Oncology\u2019s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. ALX Oncology\u2019s second pipeline candidate, ALX2004, is a novel EGFR-targeted antibody-drug conjugate with a differentiated mechanism of action and entered the clinic in a Phase 1 trial in August 2025. More information is available at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=58Ac7qaM5O07VB48oQI9TCqFwwcdT4PqTijesth5Lu1QJXJtdAepZmEbJQIvORgWtmKezo0vU4vBeo188_nt0O0V4JnnmvaxQa51hQnkDMLIGZX6dkPRd22honSqsPvuWMHCvPhX6a4YkqYXpY2rKQ0ZjeqbmIcY0kdSheaE_NEHEqhlED7mYnXUWc8hSy752qGQQoZPZ_L6BqL1wr8BPqiMwWsCk-BMdURncd3qwgwfYntyEmCGbpC30kozINjRqKOizdURbfDh35zT3MwUFw==\" rel=\"nofollow\" target=\"_blank\">www.alxoncology.com<\/a>\u00a0and on LinkedIn\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1DWEcJMJoz6X3pXYY5YqmNqffJ5rzSRYIJusaz0Xp3zAim5SpDybcYarxSO3N_9ajcpcyA4BeUUAMlwyL_USwUeqlp_ktgS413ZOp9fOuzhiCMMtGHeKIzmNzrjqxkZ4sEI0WNKSBfLFGbRxn09-k2qPX3VO91z0ZhyNLBYzz0lvaMgnlXirqlVx1-Z1qRYuWe-XtbYzg9h94JCRxtwmD4S9oTyNRPEZ9UVn2xK9G72kX6tnEgVMguAAD0vKJJT3LRqetiidXM4iwQNZouNMcpnvx8tAYau8YN8uylGpQH503WLUGiumaIqv64brpgLu\" rel=\"nofollow\" target=\"_blank\">@ALX Oncology<\/a>.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Elhan Webb, CFA, IR Consultant<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lzXbCyvEruxoPbbJgYE57nGDoX2n1EpDieXn6OpxFoqknxpgtV-mEpdYMEZo3_7dczExgxMRJqnFbPvLfifNEUCxjMXLOja05FM6TsL7Ix1PIqUT1-ChviZSILf0KyChxMvoek9Vph5xxFRvRjRa8rYy6oLc_P6O3-ezPSTp_aOxLYzyC0Cy0NqOzIIRlnXrxrZfsdOymlPmFQjaLjMmf8KitG3030L9Ag4h1EORIl3PQ-2yfJXxYT818zDHF94ebrNLc0RiYuKbZFIH-RtgAQ==\" rel=\"nofollow\" target=\"_blank\">ewebb@alxoncology.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Audra Friis, Sam Brown Healthcare Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Knl8FbNyFzi--LLcxRiSr_-jnMKkoeiTOwjs2ER4lYZ4k7LALeVPMtm8tv6FQW6SSZ2eJkrohE-u--_dX1Vd7qQZJWhXKFYZ411W4Mj0Z1X7kGugbfIXnhwykq-y1AU3LQticgfVuAaGy3G59pTC6C3yVUAQUGy9WfkFHN0PQhx6Ooo7Bm_WDkwp0KG-v9KIXYq8DbS7o-s6FZ283KaOCOo9V3nOLnfLioPUfqinBdo5jO8B9kq8BnQkpwtaVxCSstU-u4f-VPniiv3p6znS0w==\" rel=\"nofollow\" target=\"_blank\">audrafriis@sambrown.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EvB8NzmbAzdPaUAHY9w9l1O8qN3IlDXzrE3YRyRveHKEg4yDEHTzvjNlBeajiV3Q8aA1isF6JNfcX4z_ysERubtKbP9PLIO1h5r4MIvMgmQwt2UZxV54u0MpzPKAurqRNeBYxHS1JFvYwbaMPf8tu8Ljq-O-j_qMsT1O3n43K6nhum3HFgOeW3pu2SyShrt3lfROOgn0pptOqsI8I5XUps-Grxv6wSCftN7SrjxfMjqbHAg7LvRvXTvh2yLJh2Zy\" rel=\"nofollow\" target=\"_blank\"><br \/><\/a>(917) 519-9577<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDU3NmJiYjYtYmYxNS00NGMyLThkMjMtNzJiMGQ5OTZkZTM4LTEyMDQ0MTYtMjAyNS0xMS0xOC1lbg==\/tiny\/ALX-Oncology.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc., (&#8220;ALX Oncology&#8221; or the &#8220;Company&#8221;) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37th Annual Global Healthcare Conference in New York. The details of the meetings are as follows: Jefferies Global Healthcare Conference in London Format: Fireside Chat Date: Wednesday, November 19, 2025Time: 11:30 AM GMT \/ 6:30 AM ESTLocation: London, UKWebcast link: Available\u00a0here Piper Sandler 37 th Annual Global Healthcare Conference Format: Fireside ChatDate: Wednesday, December 3, 2025Time: 9:30 AM ESTLocation: New York, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ALX Oncology to Present at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-911186","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ALX Oncology to Present at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALX Oncology to Present at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc., (&#8220;ALX Oncology&#8221; or the &#8220;Company&#8221;) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37th Annual Global Healthcare Conference in New York. The details of the meetings are as follows: Jefferies Global Healthcare Conference in London Format: Fireside Chat Date: Wednesday, November 19, 2025Time: 11:30 AM GMT \/ 6:30 AM ESTLocation: London, UKWebcast link: Available\u00a0here Piper Sandler 37 th Annual Global Healthcare Conference Format: Fireside ChatDate: Wednesday, December 3, 2025Time: 9:30 AM ESTLocation: New York, &hellip; Continue reading &quot;ALX Oncology to Present at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T16:05:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ALX Oncology to Present at Upcoming Investor Conferences\",\"datePublished\":\"2025-11-18T16:05:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/\"},\"wordCount\":311,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/\",\"name\":\"ALX Oncology to Present at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM=\",\"datePublished\":\"2025-11-18T16:05:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALX Oncology to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALX Oncology to Present at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"ALX Oncology to Present at Upcoming Investor Conferences - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc., (&#8220;ALX Oncology&#8221; or the &#8220;Company&#8221;) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37th Annual Global Healthcare Conference in New York. The details of the meetings are as follows: Jefferies Global Healthcare Conference in London Format: Fireside Chat Date: Wednesday, November 19, 2025Time: 11:30 AM GMT \/ 6:30 AM ESTLocation: London, UKWebcast link: Available\u00a0here Piper Sandler 37 th Annual Global Healthcare Conference Format: Fireside ChatDate: Wednesday, December 3, 2025Time: 9:30 AM ESTLocation: New York, &hellip; Continue reading \"ALX Oncology to Present at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-18T16:05:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ALX Oncology to Present at Upcoming Investor Conferences","datePublished":"2025-11-18T16:05:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/"},"wordCount":311,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/","name":"ALX Oncology to Present at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM=","datePublished":"2025-11-18T16:05:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3ODAwNiM3MjcwNjk2IzIxOTI4NjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ALX Oncology to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/911186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=911186"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/911186\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=911186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=911186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=911186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}